SDF-1 3' UTR MUTATION DELAYS PROGRESSION TO AIDS

SDF-1 3 UTR 突变延迟进展为艾滋病

基本信息

项目摘要

SDF1-3?A is a mutation in an evolutionarily conserved region of the 3?UTR. Our working hypothesis has been that the SDF1-3?A mutation stabilizes the mRNA and thus increases the amount of transcript available for translation. This may result in an increase of SDF-1 available for binding to CXCR4 and a downregulation of surface CXCR4 expression. Careful sequencing of the 5?UTR and the open reading frame have not revealed any other polymorphisms in linkage disequilibrium with SDF1-3?A or associated with rate of disease progression. In collaborative studies, a sensitive assay for determining serum SDF-1 concentrations is being used to quantify serum SDF-1 concentrations in normal donors with the three SDF-1 genotypes. We are also examining the expression of SDF1 by quantifying mRNA SDF1 in stromal cells derived from a normal population. A full length SDF1-3?UTR construct of the wild type and SDF1-3?A UTR differing by a single nucleotide have differential abilities to stabilize mRNA when ligated to a reporter gene. Finally,we are examining the surface expression of CXCR4 using fluorescence activated flow sorting analysis quantification of peripheral blood mononuclear cells from normal donors of the three genotypes. Very preliminary data show a trend of less surface CXCR4 on cells obtained from donors of the SDF1-3?A/SDF1-3?A genotypes compared to individuals carrying the wildtype allele. These experiments are being expanded to include additional SDF1-3?A/SDF1-3?A genotypes which have been identified from a pool of normal donors. Paradoxically, SDF1- 3?A, which appears to recessively protect individuals from developing AIDS in the first decade after infection in our cohorts, has been associated with an increased dominant risk for developing non-Hodgkins lymphoma in a study of HIV-1-infected hemophiliacs and homosexuals, and infants infected by vertical transmission. We have performed a categorical analysis comparing allele and genotype frequencies between HIV seropositive cases with non-Hodgkins lymphoma and controls matched for duration of HIV-1 infection and CD4 T-cell number and have been unable to detect significant differences in allele or genotype frequencies between cases and controls. We have entered into a collaboration to perform survival analyses using Multicenter AIDS Cohort Study seroconverter participants to confirm or refute this clinically important observation. The SDF1 Gene and Progression to AIDS - Chemokines, SDF-1, HIV-1 inhibitor, lymphoma, - Human Tissues, Fluids, Cells, etc.
SDF1-3?A是位于3?非编码区进化保守区域的突变。我们的工作假设是,SDF1-3α突变稳定了mRNA,从而增加了可供翻译的转录本的数量。这可能导致可与CXCR4结合的SDF-1增加,并下调表面CXCR4的表达。对5?非编码区和开放阅读框的仔细测序没有发现与SDF1-3?A连锁不平衡或与疾病进展速度相关的任何其他多态。在合作研究中,一种测定血清SDF-1浓度的灵敏方法正被用于定量具有三种SDF-1基因的正常献血者的血清SDF-1浓度。我们还通过定量检测来自正常人群的基质细胞中SDF1的mRNA来检测SDF1的表达。野生型的全长SDF1-3非编码区和单核苷酸不同的SDF1-3非编码区在连接到报告基因时具有不同的稳定mRNA的能力。最后,我们用荧光活化流动分选分析定量检测了三种基因型的正常献血者外周血单个核细胞表面CXCR4的表达。非常初步的数据显示,与携带野生型等位基因的个体相比,来自SDF1-3?A/SDF1-3?A基因携带者的细胞表面CXCR4有减少的趋势。这些实验正在扩大,以包括从正常献血者库中鉴定出的其他SDF1-3?A/SDF1-3?A基因型。矛盾的是,在我们的队列中感染后的第一个十年里,SDF1-3?A似乎在隐性地保护个人免受艾滋病的侵袭,但在一项针对感染HIV-1的血友病患者和同性恋者以及通过垂直传播感染的婴儿的研究中,SDF1-3?A与患非霍奇金淋巴瘤的主要风险增加有关。我们进行了一项分类分析,比较了HIV血清阳性的非霍奇金淋巴瘤患者和与HIV-1感染持续时间和CD4T细胞数量匹配的对照组的等位基因和基因型频率,但未能检测到病例和对照组之间的等位基因或基因型频率的显著差异。我们进行了一项合作,利用多中心艾滋病队列研究血清转换参与者进行生存分析,以证实或驳斥这一临床上重要的观察结果。SDF1基因与艾滋病的进展--趋化因子、SDF-1、HIV-1抑制物、淋巴瘤、人体组织、体液、细胞等。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHERYL ANN WINKLER其他文献

CHERYL ANN WINKLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHERYL ANN WINKLER', 18)}}的其他基金

GENETICS OF RENAL DISEASE IN AFRICAN AMERICANS
非裔美国人肾病遗传学
  • 批准号:
    6289296
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Interactions Between HIV /HCV in Coinfected Hemophiliacs
合并感染的血友病患者中 HIV/HCV 之间的相互作用
  • 批准号:
    6951336
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Candidate Gene Polymorphisms Associated with Infect. Dis
与感染相关的候选基因多态性。
  • 批准号:
    7049814
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Genetics of Renal Disease in African Americans
非裔美国人肾病遗传学
  • 批准号:
    7291760
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Genetics of Renal Disease in African Americans
非裔美国人肾病遗传学
  • 批准号:
    7732966
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Identification of Candidate Gene Polymorphisms Associate
候选基因多态性关联的鉴定
  • 批准号:
    6762977
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Genetics of Renal Disease in African Americans
非裔美国人肾病遗传学
  • 批准号:
    6950627
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Genetics of Renal Disease in African Americans
非裔美国人肾病遗传学
  • 批准号:
    6433185
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Interactions Between HIV and HCV in Hemophiliacs
血友病患者中 HIV 和 HCV 之间的相互作用
  • 批准号:
    6559197
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Identification of Gene Polymorphisms Associated with Infectious Diseases
与传染病相关的基因多态性的鉴定
  • 批准号:
    7732987
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

How do cytokine receptors transmit signals?
细胞因子受体如何传递信号?
  • 批准号:
    DP230102422
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Deciphering novel cross-talk between innate cytokine receptors
破译先天细胞因子受体之间的新型串扰
  • 批准号:
    DP210103122
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
A dissection of transmembrane signal transduction and downstream signaling response in cytokine receptors
细胞因子受体跨膜信号转导和下游信号反应的剖析
  • 批准号:
    412345
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Fellowship Programs
Protein Translation Control of Cytokine Receptors
细胞因子受体的蛋白质翻译控制
  • 批准号:
    RGPIN-2018-04852
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Development of analysis method of inflammation-related proteins in serum using inflammatory cytokine receptors
开发利用炎症细胞因子受体分析血清中炎症相关蛋白的方法
  • 批准号:
    17K18360
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Mutations and single nucleotide polymorphisms of cytokine receptors in Kawasaki disease
川崎病细胞因子受体突变及单核苷酸多态性
  • 批准号:
    16K10020
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了